NeuroToxin, Dermal filler, Mesotherapy

TSK STERiJECT LOW DEAD SPACE Needle (LDS)

$110.00
$110.00
Shipping calculated at checkout.
In Stock
Gauge 30G, 32G, 33G
Length 9mm, 13mm
TSKID Large, Standard
Material Hard polymer, Stainless steel
Use Disposable
Cleaning N/A
Kind Sharp hypodermic needle
Product Type NeuroToxin, Dermal filler, Mesotherapy
Pay with credit card
Delivery to all states
Trustpilot

 

Minimal redundant hub space
The low dead space needle is engineered to minimize the amount of fluid retained in the needle hub after an injection, effectively reducing residual volume to near zero. By optimizing the hub design, this patented Low Dead Space (LDS) technology significantly reduces wasted medication. Each low residual needle can save up to 0.042ml per hypodermic injection, which adds up to substantial savings when administering high-value drugs. For practitioners, this means maximizing the delivered dose while minimizing product loss, ensuring both cost efficiency and precision in clinical treatments.

 

Significant product and cost savings
Using a low dead space needle provides measurable benefits for both product conservation and financial savings. The advanced LDS hub design minimizes leftover medication, making it ideal for high-cost treatments or precious pharmaceuticals such as ophthalmic drugs, neurotoxins or vaccines, including COVID-19 vaccines. By reducing residual fluid in the hub, each injection ensures that more of the medication reaches the patient, cutting down on waste and lowering overall treatment costs. In this way, the low residual needle is not only clinically efficient but also economically advantageous for healthcare providers.

 

Larger inner diameter with TSKiD™ Large
Larger low dead space needles are equipped with TSKiD™ Large barrels, incorporating enlarged inner diameters to optimize flow and injection performance. TSK has developed this specialized TSKiD™ technology in three variations—Standard, Large, and Max—allowing practitioners to choose the appropriate diameter for specific applications. For instance, a 30G needle with TSKiD™ Max barrels can increase the inner diameter by up to 65% compared to ISO standards. This enhanced diameter allows smoother product delivery, reduces injection force, and complements the low residual needle design by ensuring minimal product retention while maintaining precise, controlled injections.

 

External 360 hub threading
The low dead space needle also features external 360-degree hub threading for an exceptionally secure luer lock connection. This design prevents accidental “pop-off” of the hub under high-pressure conditions, providing practitioners with confidence during delicate or high-viscosity injections. When combined with the LDS hub design, the external threading ensures that medication is delivered safely, efficiently, and reliably every time.

 

Hard polymer hub
Durability and stability are critical in high-precision injections, which is why low residual needle hubs are manufactured from an extremely hard polymer. This rigid material prevents flexing or deformation of the hub when exposed to high pressures, ultimately reducing the risk of leakage or needle detachment. The combination of a hard polymer hub and LDS design ensures that each low dead space needle delivers consistent, predictable, and efficient results, making it an essential tool for modern medical and aesthetic procedures.

Since its founding, TSK Laboratory has focused on enhancing the precision and safety of medical and aesthetic injections through innovation and quality manufacturing. Today, TSK is globally recognized for offering complete solutions that improve both practitioner workflow and patient care.

TSK’s reputation for excellence is built on a commitment to continuous research, product development, and close collaboration with aesthetic experts worldwide.

Frequently asked questions

The TSK STERiJECT Low Dead Space Needle is designed to minimize the amount of fluid retained in the needle hub after an injection. This low dead space (LDS) technology significantly reduces the residual volume, allowing up to 0.042ml of medication to be saved per injection. By maximizing the delivered dose and minimizing waste, it ensures that a greater percentage of high-value drugs, such as neurotoxins and vaccines, reaches the patient effectively.

The TSKiD™ Large barrels feature an enlarged inner diameter that optimizes flow and enhances injection performance. For instance, a 30G needle with TSKiD™ Max barrels can increase the inner diameter by up to 65% compared to ISO standards. This improvement allows for smoother product delivery and reduced injection force, which complements the low residual needle design by ensuring minimal product retention during injections, thus enhancing overall clinical efficiency.

Yes, the TSK STERiJECT Low Dead Space Needle is particularly well-suited for high-viscosity injections. Its external 360-degree hub threading provides a secure luer lock connection, preventing accidental disconnection under high-pressure conditions. This reliability is crucial when administering thicker substances, ensuring a consistent and controlled flow of medication.

The needle hub of the TSK STERiJECT Low Dead Space Needle is made from a hard polymer, which adds durability and stability during high-precision injections. This rigid material minimizes the risk of flexing or deformation under pressure, thereby reducing the potential for leakage or needle detachment. Such features are essential for maintaining accuracy and safety in medical and aesthetic procedures.

The design of the TSK STERiJECT Low Dead Space Needle significantly reduces medication waste, which translates into cost savings for healthcare providers. By minimizing the residual fluid left in the needle hub, practitioners can ensure that more of the expensive medication is administered to the patient. This is particularly beneficial for high-cost treatments, as it maximizes the efficacy of each injection while lowering overall treatment costs.

The TSK STERiJECT Low Dead Space Needle is ideal for a variety of treatments that require precise dosing and minimal product loss. It is particularly effective for administering high-value pharmaceuticals, such as ophthalmic drugs, neurotoxins, and vaccines, including those for COVID-19. Its design ensures that clinicians can deliver accurate doses while maximizing the effectiveness of the treatments.

TSK's patented Low Dead Space technology differentiates itself by engineering a needle hub that minimizes residual fluid left after an injection. Unlike standard needles, which can retain a significant amount of medication, the LDS design allows for nearly zero residual volume. This innovation not only enhances the precision of injections but also contributes to significant savings in medication usage, making it a preferred choice for healthcare professionals.

Join professionals worldwide.

You may also like this.